Login to Your Account

J.P. Morgan Healthcare Conference

Burrill Capital Fund IV Takes on Foreign Flavor

By Marie Powers
Staff Writer

Wednesday, January 18, 2012
SAN FRANCISCO – Although most of the biotech world was starting last week with a J.P. Morgan Healthcare Conference hangover, it was business as usual for the redoubtable Steve Burrill, whose life sciences venture firm, Burrill & Co., recently added Capital Fund IV to its portfolio.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription